Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169220 · ClinicalTrials.gov registry record · Phase 4
Bowel Preparation for Inpatient Colonoscopy
A Phase 4 study, sponsored by Santa Clara Valley Health & Hospital System.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT01169220: Completed Phase 4 study, sponsored by Santa Clara Valley Health & Hospital System.
NCT01169220 is a Phase 4 study that has completed, run by Santa Clara Valley Health & Hospital System. The registered enrollment target is 55 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01169220, a Phase 4 study, has completed, sponsored by Santa Clara Valley Health & Hospital System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study will compare two strategies for bowel cleansing prior to inpatient colonoscopy: the entire preparation taken the night before the procedure versus half the preparation taken the night before the procedure, and the other half taken the morning of the procedure.
Interventions
- DRUG Go-Lytely
- DRUG Go Lytely
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
What the finished NCT01169220 record still lists
NCT01169220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Go-Lytely is the first listed.
NCT01169220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01169220 about?
NCT01169220 is a clinical study titled "Bowel Preparation for Inpatient Colonoscopy". This study will compare two strategies for bowel cleansing prior to inpatient colonoscopy: the entire preparation taken the night before the procedure versus half the preparation taken the night before the procedure, and the other half taken the morning of the procedure.
What is the current status of trial NCT01169220?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2010-07. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01169220?
The interventions under investigation include: Go-Lytely (DRUG), Go Lytely (DRUG).
Who is sponsoring clinical trial NCT01169220?
This trial is sponsored by Santa Clara Valley Health & Hospital System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01169220's enrollment target sits among peer trials
55 1218th of 2000 higher than 778 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia